IntelGenx Technologies Corp. (IGXT) Financial Statements (2023 and earlier)
Company Profile
Business Address |
6420 ABRAMS SAINT LAURENT, QC H4S 1Y2 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 9,949 | 1,038 | 580 | 4,180 | 4,904 | 4,496 | ||
Cash and cash equivalents | 3,945 | 1,591 | 612 | |||||
Short-term investments | 6,004 | 1,038 | 580 | 4,180 | 3,313 | 3,884 | ||
Receivables | 680 | 260 | 381 | 815 | 623 | 1,044 | ||
Inventory, net of allowances, customer advances and progress billings | 62 | 244 | 382 | 375 | ||||
Inventory | 62 | 244 | 382 | 375 | ||||
Prepaid expense | 105 | 162 | 170 | 462 | 203 | 566 | ||
Contract with customer, asset | 354 | ✕ | ✕ | |||||
Deposits current assets | 205 | 407 | ||||||
Other undisclosed current assets | 436 | 1,840 | 1,707 | 7,231 | 314 | 246 | ||
Total current assets: | 11,437 | 4,305 | 3,220 | 13,063 | 6,044 | 6,352 | ||
Noncurrent Assets | ||||||||
Operating lease, right-of-use asset | 1,003 | 710 | 683 | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 5,213 | 5,851 | 6,365 | 6,248 | 6,346 | 5,730 | ||
Deposits noncurrent assets | 252 | 252 | 752 | 707 | 757 | 708 | ||
Total noncurrent assets: | 6,468 | 6,813 | 7,800 | 6,955 | 7,103 | 6,438 | ||
TOTAL ASSETS: | 17,905 | 11,118 | 11,020 | 20,018 | 13,147 | 12,790 | ||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities, including: | 2,299 | 1,989 | 1,941 | 2,030 | 1,305 | 897 | ||
Other undisclosed accounts payable and accrued liabilities | 2,299 | 1,989 | 1,941 | 2,030 | 1,305 | 897 | ||
Deferred revenue | 189 | 166 | ✕ | ✕ | ✕ | |||
Debt | 4,283 | 727 | 864 | 692 | 1 | 704 | ||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 3,634 | |||
Other undisclosed current liabilities | 249 | 1,486 | 5,642 | 771 | ||||
Total current liabilities: | 7,020 | 4,368 | 8,447 | 2,722 | 2,077 | 5,235 | ||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation | 3,226 | 737 | 1,025 | 1,189 | 52 | 2,610 | ||
Long-term debt, excluding current maturities | 2,500 | 171 | 470 | 1,140 | 2 | 2,565 | ||
Finance lease, liability | 84 | 84 | ✕ | ✕ | ✕ | |||
Capital lease obligations | ✕ | ✕ | ✕ | 49 | 50 | 45 | ||
Operating lease, liability | 642 | 482 | 555 | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 79 | |||||||
Deferred income tax liabilities | 79 | ✕ | ✕ | ✕ | ||||
Other undisclosed noncurrent liabilities | 3,709 | 6,966 | 1,255 | 6,120 | 7,189 | |||
Total noncurrent liabilities: | 7,014 | 7,703 | 2,280 | 7,309 | 7,241 | 2,610 | ||
Total liabilities: | 14,034 | 12,071 | 10,727 | 10,031 | 9,318 | 7,845 | ||
Stockholders' equity | ||||||||
Stockholders' equity attributable to parent | 3,871 | (953) | 293 | 9,987 | 3,829 | 4,945 | ||
Common stock | 1 | 1 | 1 | 1 | 1 | 1 | ||
Additional paid in capital | 63,104 | 48,453 | 42,635 | 42,048 | 25,253 | 23,700 | ||
Accumulated other comprehensive loss | (1,371) | (856) | (836) | (1,166) | (637) | (1,019) | ||
Accumulated deficit | (57,863) | (48,551) | (41,507) | (30,896) | (20,788) | (17,737) | ||
Total stockholders' equity: | 3,871 | (953) | 293 | 9,987 | 3,829 | 4,945 | ||
TOTAL LIABILITIES AND EQUITY: | 17,905 | 11,118 | 11,020 | 20,018 | 13,147 | 12,790 |
Income Statement (P&L) ($ in thousands) Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
---|---|---|---|---|---|---|---|
Revenues | 1,535 | 1,544 | 742 | 1,824 | 5,195 | 5,220 | |
Revenue, net | ✕ | ✕ | ✕ | ✕ | 5,195 | 5,220 | |
Cost of revenue | (2,256) | (96) | (96) | (63) | (373) | (319) | |
Cost of goods and services sold | (2,256) | (373) | (319) | ||||
Financing interest expense | (96) | (96) | (63) | ✕ | ✕ | ||
Gross profit: | (721) | 1,448 | 646 | 1,761 | 4,822 | 4,901 | |
Operating expenses | (9,517) | (7,808) | (10,292) | (10,822) | (7,688) | (6,201) | |
Other undisclosed operating income | 2,256 | 96 | 96 | 63 | 373 | 319 | |
Operating loss: | (7,982) | (6,264) | (9,550) | (8,998) | (2,493) | (981) | |
Nonoperating expense | (1,336) | (780) | (1,110) | (1,110) | (558) | (199) | |
Investment income, nonoperating | 152 | 422 | 97 | 11 | 11 | 4 | |
Interest and debt expense | (74) | (74) | (952) | (1,237) | 417 | (203) | |
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 74 | 952 | 1,237 | (417) | 203 | ||
Loss from continuing operations before equity method investments, income taxes: | (9,392) | (7,044) | (10,660) | (10,108) | (3,051) | (1,180) | |
Other undisclosed income from continuing operations before income taxes | 74 | ||||||
Loss from continuing operations before income taxes: | (9,318) | (7,044) | (10,660) | (10,108) | (3,051) | (1,180) | |
Income tax benefit | 6 | ||||||
Net loss available to common stockholders, basic: | (9,312) | (7,044) | (10,660) | (10,108) | (3,051) | (1,180) | |
Interest on convertible debt | 549 | 452 | 457 | 607 | |||
Net loss available to common stockholders, diluted: | (8,763) | (6,592) | (10,203) | (9,501) | (3,051) | (1,180) |
Comprehensive Income ($ in thousands)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
---|---|---|---|---|---|---|---|
Net loss: | (9,312) | (7,044) | (10,660) | (10,108) | (3,051) | (1,180) | |
Comprehensive loss: | (9,312) | (7,044) | (10,660) | (10,108) | (3,051) | (1,180) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (515) | (20) | 330 | (529) | 382 | (293) | |
Comprehensive loss, net of tax, attributable to parent: | (9,827) | (7,064) | (10,330) | (10,637) | (2,669) | (1,473) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.